Colorectal cancer - Overview and Epidemiology

Colorectal Cancer: Overview and Epidemiology What Is Colorectal Cancer? Colorectal cancer, also known as bowel cancer, colon cancer, or rectal cancer, develops from uncontrolled growth of cells in the colon or rectum. The colon and rectum together form the large intestine, which is the final part of the digestive system responsible for removing water from waste and forming stool. Understanding colorectal cancer is important because it is a leading cause of cancer deaths worldwide, yet it is often preventable and highly treatable when caught early. Global Burden of Disease Colorectal cancer represents a major global health burden. Worldwide, colorectal cancer is the third most common cancer, accounting for approximately 10% of all cancer diagnoses. More than one million people are diagnosed with colorectal cancer annually, and approximately 715,000 deaths occur from the disease each year. The burden is not evenly distributed globally. Colorectal cancer is the second most common cancer in women (accounting for 9.2% of female diagnoses) and the third most common in men (10.0% of male diagnoses). More than 65% of colorectal cancer cases occur in developed countries, where incidence is highest in Australia, New Zealand, Europe, and the United States. Incidence is considerably lower in Africa and South-Central Asia, likely due to differences in both risk factors and access to screening. <extrainfo> The variation in incidence between developed and developing countries reflects differences in industrialization, diet patterns, aging populations, and healthcare infrastructure. Developing countries are experiencing rising incidence as they become more westernized, suggesting that lifestyle and environmental factors play significant roles in disease development. </extrainfo> Signs and Symptoms Recognizing symptoms of colorectal cancer is crucial for early detection. The classic warning sign is blood in the stool, which may be bright red or appear as dark, tarry stools depending on the location of the cancer in the colon. Other important symptoms include: Changes in bowel habits: Persistent constipation or diarrhea that lasts more than a few weeks Abdominal discomfort: Pain, cramping, or bloating in the abdomen or lower back Systemic symptoms: Unintentional weight loss and loss of appetite, which suggest more advanced disease Gastrointestinal symptoms: Nausea or vomiting, especially in advanced cases Anemia-related symptoms: Fatigue and weakness caused by chronic blood loss from the tumor It's important to note that having these symptoms does not mean a person has colorectal cancer—many benign conditions can cause similar symptoms. However, any persistent changes in bowel habits or blood in the stool warrant medical evaluation. Risk Factors Overview Colorectal cancer typically develops through a combination of genetic and lifestyle factors. Approximately 75–95% of colorectal cancer cases arise in people with little or no specific genetic risk, meaning that lifestyle factors drive most cases. Lifestyle factors that contribute to colorectal cancer risk include: Diet (particularly diets high in red meat and processed foods, and low in fiber) Obesity Smoking Lack of physical activity In contrast, inherited genetic disorders account for less than 5% of colorectal cancer cases, even though they carry substantially higher individual risk. Conditions like Lynch syndrome and familial adenomatous polyposis significantly increase cancer risk in affected individuals. The key takeaway is that most colorectal cancer is preventable or detectable through lifestyle modifications and screening, since genetic predisposition accounts for only a small proportion of cases. Colorectal Cancer in the United States The United States provides particularly detailed epidemiological data on colorectal cancer. In 2022, approximately 151,000 adults were expected to be diagnosed with colorectal cancer (about 106,000 colon cancers and 45,000 rectal cancers). The five-year survival rate was approximately 65% in 2014, though this has likely improved with advances in screening and treatment. Positive Trends in Older Adults For adults aged 50 years and older, incidence has been declining by approximately 2% per year from 2014 to 2018. This decline is largely attributed to increased screening programs, which detect cancers at earlier, more treatable stages. Concerning Trends in Younger Adults In stark contrast, colorectal cancer incidence and mortality in adults younger than 50 has been rising. In 2023, approximately 19,550 diagnoses and 3,750 deaths were projected among people under age 50. This represents a significant public health concern because younger patients are less likely to be screened and may present with more advanced disease. Racial and Ethnic Disparities A critical issue in U.S. colorectal cancer epidemiology is the significant disparity affecting Black Americans, who have approximately a 20% higher risk of developing colorectal cancer and a 40% higher risk of dying from it compared with other racial and ethnic groups. These disparities reflect differences in screening access, treatment options, and socioeconomic factors. <extrainfo> Additional Geographic Context In the United Kingdom, approximately 41,000 people are diagnosed with colon cancer annually, making it the fourth most common cancer. In Australia, the lifetime risk is notably high: one in 19 men and one in 28 women develop colorectal cancer before age 75, rising to one in 10 men and one in 15 women by age 85. Rising Incidence in Younger Adults: A Global Concern Studies across Europe have documented a significant increase in colorectal cancer incidence among adults younger than 55 over the past 25 years. Combined with U.S. trends showing colorectal cancer deaths becoming a leading cause of cancer mortality in people under 50, this suggests a global shift in disease patterns. The reasons for this increase in younger populations are not fully understood but likely involve changes in lifestyle, diet, obesity rates, and possibly environmental exposures. </extrainfo>